Kinetics of abacavir-induced remodelling of the major histocompatibility complex class I peptide repertoire

Kinetics of abacavir-induced remodelling of the major histocompatibility complex class I peptide repertoire

Abacavir hypersensitivity syndrome can occur in individuals expressing the HLA-B*57:01 major histocompatibility complex class I allotype when utilising the drug abacavir as a part of their anti-retroviral regimen. The drug is known to bind within the HLA-B*57:01 antigen binding cleft, leading to the...

Full description

Bibliographic Details
Main Authors:	Illing, PT, van Hateren, A, Darley, R, Croft, NP, Mifsud, NA, King, S, Kostenko, L, Bharadwaj, M, McCluskey, J, Elliott, T, Purcell, AW
Format:	Journal article
Language:	English
Published:	Frontiers Media 2021

Similar Items

Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO.
by: van Ham, M, et al.
Published: (2000)

The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire
by: Nicastri, A, et al.
Published: (2020)

A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
by: Faridi, P, et al.
Published: (2018)

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
by: Green, H, et al.
Published: (2007)

T cell receptor cross-reactivity between gliadin and bacterial peptides in celiac disease
by: Petersen, J, et al.
Published: (2019)

Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport.
by: Cerundolo, V, et al.
Published: (1995)

Presentation of antigenic peptides by products of the major histocompatibility complex.
by: Fairchild, P
Published: (1998)

The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
by: Cerundolo, V, et al.
Published: (1991)

Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
by: Vessey, S, et al.
Published: (1997)

4.A21 Stories Without Words: Photographing the First Year, Fall 2005
by: McCluskey, Keith
Published: (2005)

Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains.
by: Elliott, T, et al.
Published: (1992)

Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens.
by: Lanier, E, et al.
Published: (2004)

Genome sequencing reveals a large and diverse repertoire of antimicrobial peptides
by: Rezaei Javan, R, et al.
Published: (2018)

Genome sequencing reveals a large and diverse repertoire of antimicrobial peptides
by: Rezaei avan, R, et al.
Published: (2018)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
by: Gibb, D, et al.
Published: (2002)

Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
by: Haurum, J, et al.
Published: (1995)

Algebraic minimization and the design of two-terminal contact networks
by: McCluskey, Edward Joseph
Published: (2006)

Parking : a handbook of environmental design/
by: 249591 McCluskey, Jim
Published: (1987)

Road form and townscape/
by: 249591 McCluskey, Jim
Published: (1979)

Bioorthogonal cleavage and exchange of major histocompatibility complex ligands by employing azobenzene-containing peptides
by: Choo, Joanna A. L., et al.
Published: (2015)

Association of class I major histocompatibility heavy and light chains induced by viral peptides.
by: Townsend, A, et al.
Published: (1989)

Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
by: Musiime, V, et al.
Published: (2016)

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
by: Plebanski, M, et al.
Published: (1999)

Switching Control Systems
by: McCluskey, E. J., Jr.
Published: (2010)

P(R), ordered by homeomorphic embeddability, does not represent all posets of cardinality c2
by: Knight, R, et al.
Published: (2009)

Switching Control Systems
by: McCluskey, E. J., Jr.
Published: (2010)

Utilising Bacchi's what's the problem represented to be? (WPR) approach to analyse national school exclusion policy in England and Scotland: a worked example
by: Tawell, A, et al.
Published: (2021)

Introduction to the theory of switching circuits /
by: 268090 McCluskey, E. J.
Published: (1965)

T-cell receptor usage of major histocompatibility complex class I restricted peptide-specific T-lymphocytes.
by: Gerth, U, et al.
Published: (1995)

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
by: Mutis, T, et al.
Published: (1999)

De-risking clinical trial failure through mechanistic simulation
by: Brown, L, et al.
Published: (2022)

The biochemical mediators and mechanisms involved in chromatin conformational remodeling through the cell cycle
by: Maddaly, R, et al.
Published: (2019)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2007)

Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children.
by: LePrevost, M, et al.
Published: (2006)

Determination of class II peptide-MHC repertoires and recognition via large yeast-displayed libraries
by: Rappazzo, Charles Garrett.
Published: (2020)

Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions
by: Southcombe, J, et al.
Published: (2016)

Peptide-major histocompatibility complex dimensions control proximal kinase-phosphatase balance during T cell activation.
by: Choudhuri, K, et al.
Published: (2009)

Selection of the T cell repertoire.
by: Sebzda, E, et al.
Published: (1999)

Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum.
by: Elliott, T, et al.
Published: (1995)

Cooperation across the histocompatibility barrier.
by: Waldmann, H, et al.
Published: (1975)